Castlight Health, inc. (CSLT) Scheduled to Post Quarterly Earnings on Tuesday
Castlight Health, inc. (NYSE:CSLT) is scheduled to issue its quarterly earnings data after the market closes on Tuesday, October 31st. Castlight Health, inc. has set its FY17 guidance at ($0.28)-($0.24) EPS.
Castlight Health, inc. (NYSE:CSLT) last issued its quarterly earnings data on Wednesday, August 2nd. The software maker reported ($0.07) earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.09) by $0.02. The company had revenue of $32.10 million for the quarter, compared to the consensus estimate of $31.14 million. Castlight Health, inc. had a negative net margin of 42.54% and a negative return on equity of 36.30%. The firm’s revenue for the quarter was up 36.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned ($0.11) earnings per share. On average, analysts expect Castlight Health, inc. to post $-0.46 EPS for the current fiscal year and $-0.35 EPS for the next fiscal year.
Castlight Health, inc. (NYSE CSLT) opened at 4.20 on Tuesday. Castlight Health, inc. has a 12 month low of $3.05 and a 12 month high of $5.50. The company’s market cap is $553.09 million. The company’s 50-day moving average is $4.22 and its 200-day moving average is $4.05.
In other news, CEO John C. Doyle sold 35,184 shares of the company’s stock in a transaction on Thursday, August 17th. The shares were sold at an average price of $3.65, for a total value of $128,421.60. Following the sale, the chief executive officer now directly owns 75,639 shares of the company’s stock, valued at approximately $276,082.35. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Giovanni M. Colella sold 23,000 shares of the company’s stock in a transaction on Wednesday, August 9th. The shares were sold at an average price of $4.06, for a total transaction of $93,380.00. Following the completion of the sale, the insider now directly owns 78,906 shares in the company, valued at $320,358.36. The disclosure for this sale can be found here. Insiders sold a total of 208,287 shares of company stock worth $795,240 over the last ninety days. Insiders own 24.38% of the company’s stock.
Several analysts have weighed in on the stock. BidaskClub downgraded shares of Castlight Health, inc. from a “hold” rating to a “sell” rating in a research report on Wednesday, October 18th. Canaccord Genuity raised shares of Castlight Health, inc. from a “hold” rating to a “buy” rating in a research report on Tuesday, October 10th. Dougherty & Co reissued a “buy” rating on shares of Castlight Health, inc. in a research report on Thursday, August 17th. ValuEngine downgraded shares of Castlight Health, inc. from a “hold” rating to a “sell” rating in a research report on Thursday, August 10th. Finally, Cowen and Company reissued a “market perform” rating and set a $4.50 target price (up previously from $4.00) on shares of Castlight Health, inc. in a research report on Thursday, August 3rd. Three equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and three have assigned a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus target price of $4.63.
TRADEMARK VIOLATION NOTICE: This story was first posted by American Banking News and is the property of of American Banking News. If you are accessing this story on another website, it was illegally stolen and republished in violation of United States and international trademark and copyright law. The legal version of this story can be accessed at https://www.americanbankingnews.com/2017/10/24/castlight-health-inc-cslt-scheduled-to-post-quarterly-earnings-on-tuesday.html.
About Castlight Health, inc.
Castlight Health, Inc offers a health benefits platform that engages employees to make healthcare decisions, and enables employers to communicate and measure their benefit programs. The Company operates through cloud-based products segment. Its technology offering aggregates data and applies analytics to make healthcare data transparent.
Receive News & Ratings for Castlight Health inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health inc. and related companies with MarketBeat.com's FREE daily email newsletter.